ESMO-Webinar-series-MTB-Clinical-Practice-1000x250

Live on

13 Mar 2024 at 18:30 CET

Chair's welcome

I am pleased to extend an invitation for you to join a webinar that delves into the pivotal aspects essential for the integration of the Molecular Tumour Board (MTB) into clinical practice. This session is one of four ESMO webinars in a series centred around genomics-guided care.

I am privileged to host a panel of esteemed professionals for this webinar. Our discourse will not only explore the current role of MTB in precision oncology, but also navigate the complexities involved in establishing and managing MTBs—addressing challenges such as cost, patient accessibility, and the dynamic paradigms of drug development.

The overarching design of our programme aims to amplify patient’s access to MTB and chart the prospective trajectory of MTBs within the broader domain of oncology. By contextualising the precision medicine landscape, facilitating expert dialogues, and highlighting key considerations for MTB operations, we aspire to provide a comprehensive resource for oncologists striving to stay updated with the swiftly advancing molecular oncology techniques and their clinical implementation.

I invite you to register and join us all in this new ESMO activity.

Dr. Benedikt Westphalen
Comprehensive Cancer Centre Munich (CCC München), Ludwig Maximilian University Hospital (LMU Klinikum), Munich, Germany

Speakers

Live viewers of the webinar will be awarded a certificate of attendance.

Learning objectives:

Understand the clinical and scientific applications for different methodologies in tumour sequencing.
Recognise the multidisciplinary nature of MTBs and their current and future role in precision oncology.
Discuss potential strategies for overcoming challenges in scalability and making MTBs accessible to more patients.
Understand the future direction of MTBs in the larger landscape of oncology, considering factors like cost, patient access, and evolving drug development paradigms.

Speakers

Learning objectives:

Supported by

How to Access

You may also be interested in...